TITLE

Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature

AUTHOR(S)

Khaliq, Yasmin; Zhanel, George G.

PUB. DATE

June 2003

SOURCE

Clinical Infectious Diseases;6/1/2003, Vol. 36 Issue 11, p1404

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

With the expanded use of fluoroquinolones for the treatment of community-acquired respiratory infections and reports of tendon injury linked to the use of these agents, we reviewed the literature to investigate the frequency and strength of this association. Ninety-eight case reports were available for review. The incidence of tendon injury associated with fluoroquinolone use is low in a healthy population but increases in patients who have renal dysfunction, who are undergoing hemodialysis, or who have received renal transplants. Pefloxacin and ciprofloxacin were most frequently implicated, but tendon injury was reported with most fluoroquinolones. The median duration of fluoroquinolone treatment before the onset of tendon injury was 8 days, although symptoms occurred as early as 2 hours after the first dose and as late as 6 months after treatment was stopped. Up to one-half of patients experienced tendon rupture, and almost one-third received long-term corticosteroid therapy. Tendon injury associated with fluoroquinolone use is significant, and risk factors such as renal disease or concurrent corticosteroid use must be considered when these agents are prescribed.

ACCESSION #

10030017

 

Related Articles

• Tendon rupture linked to antibiotic.  // Drug Topics;2/6/95, Vol. 139 Issue 3, p8 

  Reports that tendon rupture has been linked to fluoroquinolone antibiotics. Revision of labeling; Number of cases reported.

• Gemifloxacin: A broad-spectrum oral quinolone for treatment of respiratory and urinary tract infections. Lomaestro, Ben M. // Formulary;Dec2000, Vol. 35 Issue 12, p961 

  Examines the pharmacokinetic and pharmacodynamic characteristics of gemifloxacin, a potent fluoroquinolone, against several pathogens. Use of gemifloxacin in the treatment of respiratory and urinary tract infections; Drug interactions; Adverse effect profile.

• Ciprofloxacin and Achilles’ tendon rupture: a causal relationship. Ozaras, Resat; Mert, Ali; Tahan, Veysel; Uraz, Suleyman; Ozaydin, Ismet; Yilmaz, Mehmet Halit; Ozaras, Nihal // Clinical Rheumatology;Dec2003, Vol. 22 Issue 6, p500 

  This article describes a case of spontaneous rupture of the Achilles' tendon associated with ciprofloxacin use on one side, and the development of the same complication on the other side 1 year later following another use of the same drug. A 32-year-old male surgeon presented with a severe pain...

• Atemnot und Gehunfähigkeit. Schuster, Stefanie; Diethelm, Markus // Praxis (16618157);7/3/2013, Vol. 102 Issue 14, p873 

  We report the case of a 73 year old patient with a COPD. A severe exazerbation was treated with glucocorticoids and Quinolones. A few days later both ankles were tender and painful. Ultrasound examination showed bilateral Achilles tendon ruptures. Diagnostics, etiology and therapeutic options...

• Four consecutive cases of Achilles tendon disorders associated with levofloxacin treatment in hemodialysis patients. Takeda, Shin-ichi; Imai, Toshimi; Chaki, Yuko; Kusano, Eiji // Clinical & Experimental Nephrology;Dec2012, Vol. 16 Issue 6, p977 

  No abstract available.

• Clinical Perspectives on New Antimicrobials: Focus on Fluoroquinolones. Talan, David A. // Clinical Infectious Diseases;3/15/2001 Supplement 1, Vol. 32, pS64 

  Respiratory tract infections are the most common infectious presentation in the community and hospital settings and are a major cause of morbidity and mortality worldwide. Recently, newer fluoroquinolones have been recommended for the treatment of these infections. Among them, moxifloxacin shows...

• New fluoroquinolone has dual activity against resistant bugs. LoBuono, Charlotte // Drug Topics;5/5/2003, Vol. 147 Issue 9, p16 

  Reports on the U.S. Food and Drug Administration's approval of gemifloxacin for the treatment of acute exacerbations of chronic bronchitis. Fourth-generation fluoroquinolone with dual activity against bacteria to treat community-acquired respiratory infections; Inhibition of DNA synthesis...

• Antibiotic Use Declines Overall, While Use of Broad-Spectrum Increases.  // Clinical Oncology Alert;Oct2009 Supplement, p1 

  The article reports on a decline in antibiotics use for the treatment of acute respiratory tract infections (ARTI) based on data obtained between 1995 and 2006. Antibiotics trends were examined using a national database for ARTI. It showed that children below the age of 5 were less likely to be...

• Antibiotic Use Declines Overall, While Use of Broad-Spectrum Increases. Elliott, William T. // Neurology Alert;Oct2010 Primary Care, p1 

  The article discusses a study which examines the use of antibiotics for acute respiratory tract infections (ARTIs). Conducted from 1995 to 2006, the study found that children under 5 years old were seen less frequently to experience ARTI compared from the past. The study also revealed that the...

Read the Article